Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0290
+0.0010 (3.57%)
At close: Nov 28, 2025
Rua Bioscience Market Cap
Rua Bioscience has a market cap or net worth of 7.08 million as of November 28, 2025. Its market cap has increased by 39.44% in one year.
Market Cap
7.08M
Enterprise Value
7.64M
Revenue
1.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since October 22, 2020, Rua Bioscience's market cap has decreased from 95.21M to 7.08M, a decrease of -92.57%. That is a compound annual growth rate of -39.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 7.08M | 15.75% |
| Dec 31, 2024 | 6.11M | -67.78% |
| Dec 29, 2023 | 18.98M | -44.14% |
| Dec 30, 2022 | 33.97M | -45.52% |
| Dec 31, 2021 | 62.37M | -25.89% |
| Dec 31, 2020 | 84.16M | -11.61% |
| Oct 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fisher & Paykel Healthcare Corporation | 21.90B |
| EBOS Group | 5.84B |
| Summerset Group Holdings | 3.04B |
| Ryman Healthcare | 2.95B |
| Oceania Healthcare | 604.73M |
| AFT Pharmaceuticals | 369.13M |
| Green Cross Health | 155.21M |
| Pacific Edge | 153.35M |